This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Innovations by Rubén Pío in Adrenomedullin Research
Introduction
Rubén Pío is a notable inventor based in Pamplona, Spain. He has made significant contributions to the field of biomedical research, particularly in the study of adrenomedullin (AM) and its associated proteins. His work focuses on the isolation and identification of AM-binding proteins, which play a crucial role in diagnosing and treating various diseases.
Latest Patents
Rubén Pío holds a patent titled "Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith." This invention provides methods for the isolation, identification, and purification of AM-binding proteins. It also outlines techniques for utilizing these purified proteins to diagnose, treat, and monitor AM-related diseases, such as those associated with abnormally elevated AM levels. The patent further describes a newly identified complex between AM and a specific AM-binding protein, factor H (fH). Additionally, it includes methods for identifying and purifying complexes of AM and an AM binding protein using anti-AM/fH antibodies, as well as methods for treating conditions like cancer or diabetes with these antibodies.
Career Highlights
Rubén Pío is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution has allowed him to contribute to significant advancements in medical research and therapeutic applications.
Collaborations
Throughout his career, Rubén Pío has collaborated with esteemed colleagues, including Frank Cuttitta and Ted H Elsasser. These collaborations have further enriched his research and expanded the impact of his innovations in the field.
Conclusion
Rubén Pío's contributions to the understanding of adrenomedullin and its binding proteins represent a significant advancement in biomedical research. His innovative methods and discoveries hold promise for improving the diagnosis and treatment of various diseases.